# Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)

> **NCT04366726** · PHASE1 · COMPLETED · sponsor: **Radius Health, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **COMBINATION_PRODUCT:** abaloparatide-sMTS

## Key facts

- **NCT ID:** NCT04366726
- **Lead sponsor:** Radius Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-09
- **Primary completion:** 2019-05-14
- **Final completion:** 2019-05-14
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04366726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04366726, "Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04366726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*